References: Methicillin-resistant Staphylococcus aureus (MRSA)

  • Curtis SJ, Marvelianto Tedjo T, Lee SJ, Rawson-Harris PJ, Sim K, Attwood LO, et al. Injecting drug use is a risk factor for methicillin resistance in patients with Staphylococcus aureus bloodstream infections. Intern Med J 2024;54(11):1903-8. https://www.ncbi.nlm.nih.gov/pubmed/39470358
  • Harch SAJ, MacMorran E, Tong SYC, Holt DC, Wilson J, Athan E, et al. High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA. BMC Infect Dis 2017;17(1):405. https://www.ncbi.nlm.nih.gov/pubmed/28592231
  • Haysom L, Cross M, Anastasas R, Hampton S, Harris M, Sneddon K. Methicillin-resistant Staphylococcus aureus skin and soft tissue infections in young people in custody in New South Wales. J Paediatr Child Health 2019;55(2):224-8. https://www.ncbi.nlm.nih.gov/pubmed/30161281
  • Haysom L, Cross M, Anastasas R, Moore E, Hampton S. Prevalence and Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Custodial Populations: A Systematic Review. J Correct Health Care 2018;24(2):197-213. https://www.ncbi.nlm.nih.gov/pubmed/29661109
  • Macmorran E, Harch S, Athan E, Lane S, Tong S, Crawford L, et al. The rise of methicillin resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia. Epidemiol Infect 2017;145(13):2817-26. https://www.ncbi.nlm.nih.gov/pubmed/28803587
  • Marschall J, Muhlemann K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol 2006;27(11):1206-12. https://www.ncbi.nlm.nih.gov/pubmed/17080378
  • Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001;32(10):1393-8. https://www.ncbi.nlm.nih.gov/pubmed/11317238
  • Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG, Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015;28(3):603-61. https://www.ncbi.nlm.nih.gov/pubmed/26016486